$914 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 61 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | Buy | PFIZER INC | $47,227,000 | +20.1% | 1,405,970 | +22.3% | 5.16% | +12.5% |
| JNJ | Buy | JOHNSON & JOHNSON | $46,837,000 | +9.8% | 354,048 | +3.4% | 5.12% | +2.9% |
| MRK | Buy | MERCK & CO INC | $46,753,000 | +2.1% | 729,483 | +1.2% | 5.11% | -4.4% |
| NVS | Buy | NOVARTIS AGsp adr | $46,684,000 | +33.1% | 559,296 | +18.4% | 5.10% | +24.6% |
| MDT | New | MEDTRONIC PLC | $35,354,000 | – | 398,360 | +100.0% | 3.87% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $30,892,000 | +1299.7% | 62,898 | +1004.4% | 3.38% | +1209.3% |
| ACAD | Buy | ACADIA PHARMACEUTICALS | $30,646,000 | +32.8% | 1,098,809 | +63.7% | 3.35% | +24.3% |
| NUVA | Buy | NUVASIVE INC | $30,252,000 | +3.3% | 393,289 | +0.3% | 3.31% | -3.2% |
| KTWO | Buy | K2M GROUP HOLDINGS | $25,047,000 | +46.0% | 1,028,219 | +22.9% | 2.74% | +36.7% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL | $22,627,000 | +75.8% | 1,808,750 | +41.4% | 2.47% | +64.6% |
| AERI | Buy | AERIE PHARMACEUTICALS | $21,161,000 | +19.8% | 402,674 | +3.4% | 2.31% | +12.2% |
| XLRN | Buy | ACCELERON PHARMA | $18,371,000 | +449.0% | 604,499 | +378.2% | 2.01% | +413.8% |
| LOXO | Buy | LOXO ONCOLOGY INC | $17,786,000 | +367.6% | 221,795 | +145.4% | 1.94% | +338.1% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL | $17,563,000 | +647.7% | 589,959 | +649.6% | 1.92% | +601.1% |
| EVH | New | EVOLENT HEALTH INC | $13,507,000 | – | 532,812 | +100.0% | 1.48% | – |
| IART | Buy | INTEGRA LIFESCIENCE | $13,300,000 | +55.9% | 243,998 | +20.5% | 1.45% | +46.0% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $12,384,000 | -2.8% | 452,781 | +31.0% | 1.35% | -8.9% |
| ENDP | Buy | ENDO INTL PLC | $9,167,000 | +12.5% | 820,699 | +12.4% | 1.00% | +5.3% |
| EVHC | Buy | ENVISION HEALTHCARE | $8,349,000 | +8.9% | 133,220 | +6.5% | 0.91% | +2.0% |
| PRTA | Buy | PROTHENA CORP PLC | $8,175,000 | +3.9% | 151,046 | +7.1% | 0.89% | -2.7% |
| IRTC | New | IRHYTHM TECHNOLOGIES | $7,868,000 | – | 185,170 | +100.0% | 0.86% | – |
| MASI | Buy | MASIMO CORP | $6,683,000 | +34.4% | 73,300 | +37.5% | 0.73% | +25.8% |
| DBVT | Buy | DBV TECHNOLOGIESsp adr | $6,398,000 | +36.1% | 179,152 | +34.2% | 0.70% | +27.5% |
| AGIO | Buy | AGIOS PHARMACEUTICALS | $6,359,000 | +112.7% | 123,599 | +141.4% | 0.70% | +99.1% |
| ONCE | New | SPARK THERAPEUTICS | $6,052,000 | – | 101,300 | +100.0% | 0.66% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $3,887,000 | +701.4% | 188,712 | +833.1% | 0.42% | +645.6% |
| CLVS | New | CLOVIS ONCOLOGY | $2,987,000 | – | 31,900 | +100.0% | 0.33% | – |
| ILMN | Buy | ILLUMINA INC | $2,924,000 | +51.0% | 16,850 | +48.5% | 0.32% | +41.6% |
| INCY | Buy | INCYTE CORPORATION | $2,751,000 | +20.0% | 21,845 | +27.4% | 0.30% | +12.3% |
| CI | New | CIGNA CORP | $2,596,000 | – | 15,510 | +100.0% | 0.28% | – |
| INSM | Buy | INSMED INC | $2,502,000 | +29.2% | 145,799 | +31.8% | 0.27% | +21.2% |
| VSAR | New | VERSARTIS INC | $1,828,000 | – | 104,757 | +100.0% | 0.20% | – |
| OBSV | Buy | OBSEVA SA | $1,820,000 | +131.6% | 212,831 | +181.9% | 0.20% | +116.3% |
| IMDZ | New | IMMUNE DESIGN CORP | $1,641,000 | – | 168,300 | +100.0% | 0.18% | – |
| SBPH | New | SPRING BK PHARMACEUTICALS | $1,523,000 | – | 112,500 | +100.0% | 0.17% | – |
| Buy | TRILLIUM THERAPEUTICS | $806,000 | +2.2% | 183,272 | +42.9% | 0.09% | -4.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.